Pilot study to test and validate the applicability of a bioanalytical assay for betahistine in plasma after administration of a single dose betahistine 24 mg IR tablet
Not Applicable
Completed
- Registration Number
- CTRI/2011/08/001934
- Lead Sponsor
- Abbott Healthcare Products BV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 8
Inclusion Criteria
�BMI 18 - 28 kg/m2
Exclusion Criteria
?Subjects who participated in a previous betahistine trial
?Subjects who can not communicate reliable with the investigator
?Subjects who are unlikely to co-operate with the requirements of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method